ClinicalTrials.govpublic full text
Trial of RAD001 and Erlotinib With Recurrent Head and Neck Squamous Cell Carcinoma
head and neck cancer, head and neck, squamous cell carcinoma, rad001, erlotinib, everolimus, osi-774, tarceva, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 835382
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.